The Impact of Preclinical High Potent P2Y 12 Inhibitors on Decision Making at Discharge and Clinical Outcomes in Patients with Acute Coronary Syndrome.

Andreas HammerMario KrammelPatrick AignerGeorg PfennebergerSebastian SchnaubeltFelix HoferNiema KazemLorenz KollerEva SteinacherUlrike BaumerChristian HengstenbergAlexander NiessnerPatrick Sulzgruber

Published in: Journal of clinical medicine (2023)

did not influence the cardiac outcome from a long-term perspective.

Keyphrases

decision making
left ventricular
cell therapy
stem cells
heart failure